Ulisse Biomed Secures €10 Million Investment Deal
Deal News | Aug 07, 2025 | Finance Community IT - 3 Private Equity
Ulisse Biomed, an Euronext Growth Milan-listed company in diagnostics, theranostics, and therapeutics, has entered an equity financing agreement worth up to €10 million with US family office Global Corporate Finance. The legal firm Lexia assisted in structuring and facilitating this transaction, which includes mandatory capital subscription upon request and free warrant allocations to the investor. These warrants have a set strike price much higher than the present market values and are exercisable within five years. The transaction comprises the ability for Ulisse Biomed to raise a further €5 million through a reserved capital increase linked to the warrants. This strategic move provides Ulisse Biomed with flexible, rapid, and tailored capital solutions to enhance its industrial plans, fortify R&D activities, and support potential extraordinary operations.
Sectors
- Diagnostics and Medical
- Private Equity and Investment
- Legal Advisory
Geography
- Italy – Ulisse Biomed is listed on Euronext Growth Milan, indicating its base and primary operations in Italy.
- USA – Global Corporate Finance, the investing family office, is based in the US.
Industry
- Diagnostics and Medical – Relevant due to Ulisse Biomed's operations in the diagnostics, theranostics, and therapeutics sectors.
- Private Equity and Investment – Relevant as the article discusses an investment from a family office, a typical segment of private equity.
- Legal Advisory – Relevant as the transaction involved legal assistance from Lexia, spotlighting legal advisory involvement in financial deals.
Financials
- 10 million – The total amount of equity financing agreed upon between Ulisse Biomed and Global Corporate Finance.
- 5 million – An additional capital increase tied to the potential exercise of warrants.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Ulisse Biomed | Target Company | Company | An Italian company listed on Euronext Growth Milan, operating in diagnostics, theranostics, and therapeutics. |
| Global Corporate Finance | Investor | Company | A US-based family office providing the equity investment in Ulisse Biomed. |
| Lexia | Legal Advisor | Company | A legal firm that assisted Ulisse Biomed in structuring the investment deal. |